Raja Siva, Ching Jesus, Xi Liqiang, Hughes Steven J, Chang Ronald, Wong Wendy, McMillan William, Gooding William E, McCarty Kenneth S, Chestney Melissa, Luketich James D, Godfrey Tony E
Department of Surgery, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Clin Chem. 2005 May;51(5):882-90. doi: 10.1373/clinchem.2004.046474. Epub 2005 Mar 3.
PCR-based assays can improve clinical care, but they remain technically demanding and labor-intensive. We describe a new instrument, the GeneXpert, that performs automated nucleic acid isolation, reverse transcription, and fluorescence-based quantitative PCR in approximately 35 min.
Yield and integrity of RNA isolated on the GeneXpert were compared with Qiagen-based extraction for parallel samples (5-microm frozen tissue sections). The reproducibility of automated RNA isolation, reverse transcription, and quantitative PCR was determined by replicate (n = 10) analysis of 10 tissues, using duplex (target and endogenous control) reverse transcription-PCR reactions for two gene combinations. The GeneXpert was then used to perform rapid analysis of lymph nodes from melanoma, breast cancer, and lung cancer patients and analysis of melanoma metastatic to the lung, primary lung adenocarcinoma, and healthy lung tissue.
On the GeneXpert, RNA was recovered in slightly over 6 min, and the yield was approximately 70% of that from parallel Qiagen reactions. The RNA integrity was comparable to that of Qiagen-isolated RNA as determined by gel electrophoresis. For the melanoma samples, the 95% prediction interval for the deltaCt for a new measurement was +/-1.54 cycles, and for breast cancer samples, the interval for a newly observed deltaCt was +/-1.40 cycles. GeneXpert assays successfully detected the presence of metastatic melanoma, breast cancer, and lung cancer in lymph nodes and also differentiated among metastatic melanoma, lung adenocarcinoma, and healthy lung.
RNA yield and integrity on the GeneXpert are comparable to benchtop methods. Reproducibility of the GeneXpert data is similar to that seen with manual methods in our hands but may need improvement for some applications. The GeneXpert can perform RNA isolation, reverse transcription, and quantitative PCR in approximately 35 min and could therefore be used for intraoperative testing when applicable.
基于聚合酶链反应(PCR)的检测方法可改善临床护理,但技术要求高且劳动强度大。我们描述了一种新型仪器——GeneXpert,它能在约35分钟内完成自动核酸提取、逆转录及基于荧光的定量PCR。
将GeneXpert上提取的RNA产量和完整性与基于Qiagen的平行样本(5微米冷冻组织切片)提取方法进行比较。通过对10个组织进行重复(n = 10)分析,使用针对两种基因组合的双链(靶标和内源性对照)逆转录 - PCR反应,确定自动RNA提取、逆转录和定量PCR的可重复性。然后使用GeneXpert对黑色素瘤、乳腺癌和肺癌患者的淋巴结进行快速分析,并对转移至肺部的黑色素瘤、原发性肺腺癌和健康肺组织进行分析。
在GeneXpert上,RNA在略超过6分钟内回收,产量约为平行Qiagen反应的70%。通过凝胶电泳测定,RNA完整性与Qiagen提取的RNA相当。对于黑色素瘤样本,新测量的ΔCt的95%预测区间为±1.54个循环,对于乳腺癌样本,新观察到的ΔCt的区间为±1.40个循环。GeneXpert检测成功检测到淋巴结中转移性黑色素瘤、乳腺癌和肺癌的存在,还能区分转移性黑色素瘤、肺腺癌和健康肺组织。
GeneXpert上的RNA产量和完整性与台式方法相当。GeneXpert数据的可重复性与我们手动方法的类似,但某些应用可能需要改进。GeneXpert可在约35分钟内完成RNA提取、逆转录和定量PCR,因此在适用时可用于术中检测。